The invention discloses a traditional Chinese medicine composition for treating malignant lymphoma. The composition comprises Angelica, Ligusticum wallichii, radix paeoniae rubra, rehmanniae radix, Radix Scrophulariae, edible tulip, airpotato yam, seaweed, kelp, prunella vulgaris, oyster, Paris polyphylla, trigone, rhizoma curcumae, Rhizoma Cyperi, scorpion, centipede, semen brassicae, pericarpium citri reticulatae viride, Fructus aurantii and Radix bupleuri. The invention uses methods of reducing phlegm and resolving masses, and regulating qi and dissipating stasis. Aiming at the etiology and pathogenesis of malignant lymphoma, the invention provides a novel treatment concept: occurrence, development and ending of malignant lymphoma lay in qi. Qi stagnation causes blood stasis, and blood stasis causes phlegm accumulation, and phlegm accumulation causes abdominal masses, which lead to tumor. Accordingly, the invention adopts a group of traditional Chinese medicines which can permeate qifen. Rectifying qi can smooth the liver, and guiding qi downward can realize smoothness, and relieving stagnant qi can dissipate stasis. Ancient medicine believes in invigorating the spleen to eradicate source of phlegm, and today the invention utilizes pectoral qi to eliminate the foundation of tumor, so as to treat lymphatic cancer from the foundation; and coupled with medicines for dissipating phlegm, the lymphatic cancer can be cured. All parties are played together to smooth the liver, rectify qi, draw out poison, relieve swelling, break masses, dissipate stasis, benefit water-dampness, relieve phlegm coagulation, reduce cancer, strengthen the body resistance to eliminate pathogenic factors and resist cancer.